Construction sources buzzing about a new set of headaches and hurdles facing AstraZeneca’s beleaguered, $650M HQ project
Has AstraZeneca’s gleaming, $650 million HQ project in Cambridge, UK hit a new set of delays and cost overruns?
Those are the big questions that …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
